Illinois SR 394: OVARIAN CANCER AWARENESS MO.

Status: Resolution Adopted (as of 2025-10-15)

State: Illinois · Session: 104th · Bill: SR 394

Sponsors: Sara Feigenholtz

Bill Text

• 

 Illinois General Assembly - Full Text of SR0394 

• 

• 

• 

• 

• 

• 

• 

• 

• 

• 

• 

• 

 Select Language

 × 

 The Illinois General Assembly offers the Google Translate™ service for visitor convenience. In no way should it be considered accurate as to the translation of any content herein.

 Visitors of the Illinois General Assembly website are encouraged to use other translation services available on the internet.

 The English language version is always the official and authoritative version of this website.

 NOTE: To return to the original English language version, select the "Show Original" button on the Google Translate™ menu bar at the top of the window.

 Choose Language 

 English 

 Afrikaans 

 Albanian 

 Arabic 

 Armenian 

 Azerbaijani 

 Basque 

 Bengali 

 Bosnian 

 Catalan 

 Croatian 

 Czech 

 Danish 

 Dutch 

 Esperanto 

 Estonian 

 Filipino 

 Finnish 

 French 

 Galician 

 Georgian 

 German 

 Greek 

 Gujarati 

 Haitian Creole 

 Hausa 

 Hawaiian 

 Hebrew 

 Hindi 

 Hungarian 

 Icelandic 

 Indonesian 

 Interlingua 

 Interlingue 

 Inuktitut 

 Irish 

 Italian 

 Japanese 

 Javanese 

 Kannada 

 Khmer 

 Korean 

 Latin 

 Latvian 

 Lithuanian 

 Luxembourgish 

 Macedonian 

 Malagasy 

 Malayalam 

 Maltese 

 Maori 

 Marathi 

 Myanmar 

 Nepali 

 Norwegian 

 Odia 

 Pashto 

 Punjabi 

 Romanian 

 Russian 

 Samoan 

 Sango 

 Sanskrit 

 Sardinian 

 Sindhi 

 Sinhala 

 Slovak 

 Slovenian 

 Somali 

 Southern Sotho 

 Spanish 

 Sundanese 

 Swahili 

 Swedish 

 Tamil 

 Telugu 

 Thai 

 Tigrinya 

 Tonga 

 Turkish 

 Ukrainian 

 Urdu 

 Vietnamese 

 Welsh 

 Xhosa 

 Yiddish 

 Yoruba 

 Zulu 

 Powered by Translate 

 Close 

 Illinois General Assembly

 Top Navigation Bar

 Translate 

 Learn 

 Select General Assembly 

 Search the 104th General Assembly 

 Enter search terms for legislation, members, committees, or schedules. 

 ILGA.GOV 

• 

• 

 LEGISLATION & LAWS 

• Bills & Resolutions 

• Public Acts 

• Illinois Compiled Statutes 

• Illinois Constitution 

• Search Legislation 

• Glossary 

• Guide 

• 

 Reports & Inquiry 

• Legislative Reports 

• Special Reports 

• FTP Site 

• Legislator Lookup 

• Capitol Complex Phone Numbers 

• 

 Rules & Regulations 

• Illinois Register 

• Administrative Rules 

• 

 Senate 

• 
 Members 

• Schedules 

• Committees 

• 

 Request for Remote Testimony 

• Journals 

• Transcripts 

• Rules 

• Audio/Video 

• FOIA Information 

• Senate Employment Opportunities 

• Media Guidelines 

• 

 House 

• 
 Members 

• Schedules 

• Committees 

• 

 Submit testimony for House Committees 

• Journals 

• Transcripts 

• Rules 

• Audio/Video 

• FOIA Information 

• House Employment Opportunities 

• Log In 

 Mobile Top Bar

 Search the 104th General Assembly 

 Enter keywords to search the Illinois General Assembly website. 

 Full Text of SR0394

• Home 

• Legislation 

• Full Text 

 SR0394 - 104th General Assembly 

• 
 Bill Status 

• 
 Full Text 

• 
 Votes 

• 
 Witness Slips 

 Select Menu 

 Bill Status 
 Full Text 
 Votes 
 Witness Slips 
 Printer Friendly Version 

 Introduced 

 Printer Friendly Version 

 Introduced 

 Open PDF 

SR0394LRB104 14115 LAW 27247 r

1SENATE RESOLUTION

2 WHEREAS, Ovarian cancer is the fifth-leading cause of 

3cancer deaths of women in the United States and causes more 

4deaths than any other gynecologic cancer; and

5 WHEREAS, In the United States, a woman's lifetime risk of 

6being diagnosed with ovarian cancer is approximately 1 in 78; 

7and

8 WHEREAS, The American Cancer Society estimates 20,890 

9cases of ovarian cancer will be newly diagnosed in 2025 and 

1012,730 individuals will die from the disease nationwide, 

11including 770 new cases and 410 deaths in Illinois; and

12 WHEREAS, The five-year survival rate for ovarian cancer is 

1350%, although survival rates vary greatly depending on the 

14stage of diagnosis, such as individuals who are diagnosed with 

15ovarian cancer in its early stages having a survival rate of 

16over 90%; and

17 WHEREAS, While a mammogram can detect breast cancer and a 

18Pap smear can detect cervical cancer, there is no reliable 

19early detection test for ovarian cancer; and

20 WHEREAS, In June 2007, the first national consensus 

SR0394- 2 -LRB104 14115 LAW 27247 r

1statement on ovarian cancer symptoms was developed to provide 

2consistency in describing symptoms to make it easier for women 

3to learn and remember those symptoms; and

4 WHEREAS, Black women with ovarian cancer are more likely 

5to have late-stage diagnoses, receive lower quality clinical 

6services, and have lower five-year survival rates than 

7non-Black women; and

8 WHEREAS, Women of color, low-income women, and women 

9living in rural areas have more barriers to accessing standard 

10quality of care and are more likely to receive care at a 

11facility that has poorer adherence to National Comprehen

View Illinois SR 394 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.